0001209191-23-036314.txt : 20230612
0001209191-23-036314.hdr.sgml : 20230612
20230612162712
ACCESSION NUMBER: 0001209191-23-036314
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230609
FILED AS OF DATE: 20230612
DATE AS OF CHANGE: 20230612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilliss Catherine
CENTRAL INDEX KEY: 0001611008
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 231008461
MAIL ADDRESS:
STREET 1: C/O CHIMERIX, INC.
STREET 2: 2505 MERIDIAN PARKWAY, SUITE 340
CITY: DURHAM
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-09
0
0001117480
CHIMERIX INC
CMRX
0001611008
Gilliss Catherine
C/O CHIMERIX, INC.
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM
NC
27713
1
0
0
0
0
Stock Option (Right to Buy)
1.39
2023-06-09
4
A
0
60000
0.00
A
2033-06-08
Common Stock
60000
60000
D
The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2024 annual stockholder meeting.
/s/ Michael Alrutz, Attorney-In-Fact
2023-06-12